Ms. Streisand, who founded the Barbra Streisand Women’s Heart Center at Cedars-Sinai in Los Angeles and co-founded the Women’s Heart Alliance, is in Washington this week to lobby for more and better research on women’s heart health. While some progress has been made, women are still underrepresented in many areas of research related to cardiovascular health. For example, Ms. Streisand notes only 1 of 3 study participants are women in the 57 clinical trials for cardiovascular drugs.
The imbalance in research could skew results and result in ineffective applications for female patients, she writes.
In the op-ed, Ms. Streisand called for greater awareness of the issue, policy change, more funding for female-oriented research, and application of new and existing knowledge in preventive care and treatment.
Read the full op-ed here.
More articles on leadership and management:
Feds won’t approve lifetime limits on Medicaid
8 thoughts on business development and growth
Oregon legislators consider reviving state-backed insurance exchange
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
